Ignite Creation Date:
2024-05-06 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06239740
Status:
COMPLETED
Last Update Posted:
2024-02-02
First Post:
2024-01-12
Brief Title:
Effects of Electroacupuncture on Cognitive Symptoms in Major Depressive Disorder
Sponsor:
Thammasat University
Organization:
Thammasat University
Study Overview
Official Title:
Effects of Electroacupuncture on Cognitive Symptoms in Major Depressive Disorder A Pilot Study and Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ELECACU-COG-Pi
Brief Summary:
The goal of this pilot Study and Randomized Controlled Trial is to investigate the impact of electroacupuncture on cognitive function quality of life QoL and depression severity in patients with major depressive disorder MDD
The main questions it aims to answer are
Primary electroacupuncture has the potential to treat subjective cognitive complaints and cognitive impairment in MDD outpatients
Secondary electroacupuncture has the potential to treat depressive in MDD outpatients The 60 participants will randomly be assigned to either the treatment group or the control group in a 11 ratio The treatment group will undergo electroacupuncture EA while the control group will receive sham acupuncture within 10 weeks period
Both groups will receive antidepressants with adjunctive medication ie benzodiazepines tricyclics or antipsychotics as the standard treatment All participants will be assessed for executive functions and memory using specific cognitive tests including the Trail Making Test B TMT-B Stroop Color and Word Test SCWT category delayed recall in the Alzheimers Disease Assessment Scale-Cognitive Subscale ADAS-Cog and subjective reports of concern regarding concentration memory problem-solving learning communication and quality of life QoL concerns using the WHO Disability Assessment Schedule WHODAS 20 sections D11-16 and H1-3 and depressive symptoms were assessed using the Thai-PHQ-9
The main questions it aims to answer are
Primary electroacupuncture has the potential to treat subjective cognitive complaints and cognitive impairment in MDD outpatients
Secondary electroacupuncture has the potential to treat depressive in MDD outpatients The 60 participants will randomly be assigned to either the treatment group or the control group in a 11 ratio The treatment group will undergo electroacupuncture EA while the control group will receive sham acupuncture within 10 weeks period
Both groups will receive antidepressants with adjunctive medication ie benzodiazepines tricyclics or antipsychotics as the standard treatment All participants will be assessed for executive functions and memory using specific cognitive tests including the Trail Making Test B TMT-B Stroop Color and Word Test SCWT category delayed recall in the Alzheimers Disease Assessment Scale-Cognitive Subscale ADAS-Cog and subjective reports of concern regarding concentration memory problem-solving learning communication and quality of life QoL concerns using the WHO Disability Assessment Schedule WHODAS 20 sections D11-16 and H1-3 and depressive symptoms were assessed using the Thai-PHQ-9
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Thammasat University | OTHER | Faculty of Medicine Thammasat University | None |